An analysis of the optimal capital structure changes of selected generic pharmaceutical companies during the crisisGorenc, Tanja (Avtor) Berk, Aleš (Mentor) farmacevtska industrijaindustrijsko podjetjekapitalstrukturaoptimizacijakrizeprimeriKrka[T. Gorenc]20122014-07-11 13:49:06Magistrsko delo/naloga16816UDK: 658COBISS_ID: 21407462sl